Published in J Virol on March 02, 2011
Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination. J Virol (2015) 0.89
Nodular inflammatory foci are sites of T cell priming and control of murine cytomegalovirus infection in the neonatal lung. PLoS Pathog (2013) 0.88
Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model. Cell Mol Immunol (2014) 0.85
Murine CMV Infection Induces the Continuous Production of Mucosal Resident T Cells. Cell Rep (2015) 0.82
Murine Cytomegalovirus Exploits Olfaction To Enter New Hosts. MBio (2016) 0.78
A mouse model of interstitial pneumonitis induced by murine cytomegalovirus infection after allogeneic skin transplantation. Biomed Res Int (2013) 0.75
Breastfeeding and the use of human milk. Pediatrics (2005) 13.28
Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med (1982) 3.66
Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet (2001) 3.36
Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA (2003) 3.22
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol (1994) 2.68
The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia (2002) 2.37
Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med (2002) 2.32
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis (2004) 2.29
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med (1994) 2.26
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med (1994) 2.17
Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun (1981) 2.08
Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol (1979) 2.01
Latent murine cytomegalovirus infection in macrophages. Virology (1997) 1.91
Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol (1995) 1.91
The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J Exp Med (1999) 1.88
Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol (1977) 1.79
Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr (1999) 1.78
Incidence and clinical manifestations of breast milk-acquired Cytomegalovirus infection in low birth weight infants. J Perinatol (2005) 1.75
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol (2002) 1.66
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65
Cellular localization of latent murine cytomegalovirus. J Virol (1998) 1.62
Cytomegalovirus in human milk. N Engl J Med (1972) 1.60
Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol (2006) 1.59
Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol (1999) 1.59
Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci (1999) 1.56
Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am J Neuroradiol (1994) 1.52
Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics (1983) 1.42
Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J (1998) 1.35
Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods (2000) 1.33
A mouse model for cytomegalovirus infection. Curr Protoc Immunol (2001) 1.32
Cytomegalovirus infection associated with pregnancy. Lancet (1967) 1.26
Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann Neurol (1992) 1.25
Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol (2003) 1.21
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol (1998) 1.20
Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med (1987) 1.19
Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab Invest (2000) 1.17
Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers. Pediatr Infect Dis J (1991) 1.16
Congenital cytomegalovirus infection and disease. Adv Pediatr Infect Dis (1996) 1.13
Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis (2001) 1.13
MHC class I immune evasion in MCMV infection. Med Microbiol Immunol (2008) 1.10
Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol (1997) 1.09
Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch Virol (1995) 1.08
Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J Clin Microbiol (2005) 1.06
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest (2010) 1.04
Acquired cytomegalovirus infection in preterm infants. Am J Dis Child (1979) 1.04
Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc Natl Acad Sci U S A (1994) 1.03
Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology (2000) 1.02
Altered development of the brain after focal herpesvirus infection of the central nervous system. J Exp Med (2008) 1.02
Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J Virol (2008) 0.99
Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J Clin Virol (2009) 0.98
Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology (1996) 0.96
The milk mononuclear phagocyte. Pediatrics (1979) 0.96
Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system. J Virol (2002) 0.96
Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am J Neuroradiol (2003) 0.95
CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. J Immunol (2008) 0.95
Congenital and perinatal cytomegalovirus infections: clinical characteristics and pathogenic factors. Birth Defects Orig Artic Ser (1984) 0.95
Studies of latent cytomegalovirus infection: the macrophage as a virus-harboring cell. Microbiol Immunol (1985) 0.92
Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice. Clin Exp Immunol (1994) 0.92
Transmission of cytomegalovirus to mothers by infected infants: another reason to prevent transfusion-acquired infections. Pediatr Infect Dis (1983) 0.91
Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain. J Virol (2004) 0.91
Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr (2005) 0.86
Transmission of maternal cytomegalovirus-specific immunity in the guinea pig. Clin Immunol Immunopathol (1985) 0.84
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues. Med Microbiol Immunol (2008) 0.83
Congenital cytomegalovirus infection: a retrospective diagnosis in a child with pachygyria. Pediatr Neurol (2000) 0.78
Cytomegalic inclusion disease: intrauterine sonographic diagnosis using findings involving the brain. AJNR Am J Neuroradiol (1991) 0.76
Cytokine control of memory T-cell development and survival. Nat Rev Immunol (2003) 5.99
Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol (2005) 5.83
Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol (2002) 4.36
Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity (2008) 4.25
Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity (2007) 4.17
Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity (2004) 4.08
Genomic analyses identify distinct patterns of selection in domesticated pigs and Tibetan wild boars. Nat Genet (2013) 3.41
Dendritic cells maximize the memory CD8 T cell response to infection. Immunity (2005) 3.21
Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet (2011) 3.15
Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol (2004) 3.15
Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol (2011) 3.03
Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J (2004) 2.81
Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity (2006) 2.78
Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol (2006) 2.69
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol (2005) 2.48
IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J Immunol (2003) 2.42
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res (2005) 2.32
Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem (2004) 2.26
Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-18 secretion in response to Listeria monocytogenes. J Immunol (2006) 2.21
Regional and mucosal memory T cells. Nat Immunol (2011) 2.21
Role of photoreceptor-specific retinol dehydrogenase in the retinoid cycle in vivo. J Biol Chem (2005) 2.15
A comparison of strict face-down positioning with adjustable positioning after pars plana vitrectomy and gas tamponade for rhegmatogenous retinal detachment. Retina (2015) 2.06
CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc Natl Acad Sci U S A (2009) 2.01
Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells. Blood (2003) 2.00
An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. Neuron (2007) 1.98
Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity (2006) 1.95
Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol (2004) 1.93
Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med (2002) 1.89
Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway. Eur J Immunol (2006) 1.87
γδ T cells exhibit multifunctional and protective memory in intestinal tissues. Immunity (2013) 1.85
Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis. PLoS Med (2005) 1.83
In situ imaging of the endogenous CD8 T cell response to infection. Science (2007) 1.78
A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet (2011) 1.77
Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc Natl Acad Sci U S A (2007) 1.71
ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochem Biophys Res Commun (2003) 1.70
Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One (2012) 1.70
Persistent antigen presentation after acute vesicular stomatitis virus infection. J Virol (2006) 1.68
Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression. Proc Natl Acad Sci U S A (2004) 1.68
Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J Immunol (2011) 1.66
Genetic structure and diversity of cultivated soybean (Glycine max (L.) Merr.) landraces in China. Theor Appl Genet (2008) 1.62
Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal (2005) 1.60
Fully functional memory CD8 T cells in the absence of CD4 T cells. J Immunol (2004) 1.59
Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J Immunol (2002) 1.58
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol (2011) 1.58
B38: an all-boron fullerene analogue. Nanoscale (2014) 1.58
Functional characterization of rhodopsin monomers and dimers in detergents. J Biol Chem (2004) 1.57
Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol (2008) 1.56
Minding the gaps to promote thrombus growth and stability. J Clin Invest (2005) 1.53
Reconstitution of human Ero1-Lalpha/protein-disulfide isomerase oxidative folding pathway in vitro. Position-dependent differences in role between the a and a' domains of protein-disulfide isomerase. J Biol Chem (2008) 1.53
Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J Clin Endocrinol Metab (2009) 1.49
Early signals during CD8 T cell priming regulate the generation of central memory cells. J Immunol (2010) 1.49
Dissecting yield-associated loci in super hybrid rice by resequencing recombinant inbred lines and improving parental genome sequences. Proc Natl Acad Sci U S A (2013) 1.48
Memory CD8+ T cell differentiation. Ann N Y Acad Sci (2010) 1.47
Drug 'hot-spots', alcohol availability and violence. Drug Alcohol Rev (2005) 1.45
Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development. J Immunol (2006) 1.43
Predicted novel high-pressure phases of lithium. Phys Rev Lett (2011) 1.42
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care (2011) 1.41
Satisfaction with mental health care among people with multiple sclerosis in urban and rural areas. Psychiatr Serv (2006) 1.41
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci U S A (2004) 1.39
Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J Immunol (2007) 1.39
Avidity maturation of memory CD8 T cells is limited by self-antigen expression. J Exp Med (2008) 1.38
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A (2012) 1.38
Environmental cues dictate the fate of individual CD8+ T cells responding to infection. Immunity (2013) 1.38
Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One (2010) 1.37
Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey. J Virol (2003) 1.37
Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol (2007) 1.35
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res (2003) 1.33
Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A (2006) 1.32
Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed Engl (2009) 1.30
An atlas of DNA methylomes in porcine adipose and muscle tissues. Nat Commun (2012) 1.28
Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annu Rev Immunol (2006) 1.27
Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function. J Immunol (2011) 1.24
CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen. J Immunol (2006) 1.24
COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J (2003) 1.24
Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol (2011) 1.24
Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett (2006) 1.22
Early events governing memory CD8+ T-cell differentiation. Int Immunol (2010) 1.22
Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J (2006) 1.22
Repertoire of porcine microRNAs in adult ovary and testis by deep sequencing. Int J Biol Sci (2011) 1.22
A proteome reference map and proteomic analysis of Bifidobacterium longum NCC2705. Mol Cell Proteomics (2006) 1.22
Identification and characterization of HTD2: a novel gene negatively regulating tiller bud outgrowth in rice. Planta (2009) 1.21
Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS One (2011) 1.20
Slow unfolded-state structuring in Acyl-CoA binding protein folding revealed by simulation and experiment. J Am Chem Soc (2012) 1.19
Identification and characterization of NARROW AND ROLLED LEAF 1, a novel gene regulating leaf morphology and plant architecture in rice. Plant Mol Biol (2010) 1.19
The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both? Int J Biochem Cell Biol (2005) 1.18
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects. J Infect Dis (2012) 1.18
Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 1.18
m-Bop, a repressor protein essential for cardiogenesis, interacts with skNAC, a heart- and muscle-specific transcription factor. J Biol Chem (2002) 1.17
Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol (2002) 1.17
Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res (2009) 1.17
In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection. Eur J Immunol (2008) 1.16
Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription. J Mol Biol (2010) 1.16
A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results. HIV Clin Trials (2012) 1.13
Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol Aging (2006) 1.13